Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR Function
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This study is a multiple within participant crossover study to evaluate the effect of
ivacaftor on lung function in participants aged 12 years and older with cystic fibrosis (CF)
who have phenotypic or molecular evidence of residual CF transmembrane conductance regulator
(CFTR) function.